99 related articles for article (PubMed ID: 8010393)
1. [Serum E2 and progesterone levels in patients with atypical hyperplasia and endometrial carcinoma].
Gorchev G; Maleeva A
Akush Ginekol (Sofiia); 1993; 32(2):23-4. PubMed ID: 8010393
[TBL] [Abstract][Full Text] [Related]
2. [The effect of E2 and progesterone on the receptor status in endometrial carcinoma].
Gorchev G; Milkov V; Tanchev S; Popov I
Akush Ginekol (Sofiia); 1992; 31(2):27-8. PubMed ID: 1342552
[TBL] [Abstract][Full Text] [Related]
3. [The pathogenetic relationships between atypical hyperplasia, endometrial carcinoma and the E2 and progesterone levels].
Gorchev G
Akush Ginekol (Sofiia); 1993; 32(3):48-9. PubMed ID: 8037323
[No Abstract] [Full Text] [Related]
4. Leptin levels in serum depending on Body Mass Index in patients with endometrial hyperplasia and cancer.
Cymbaluk A; Chudecka-Głaz A; Rzepka-Górska I
Eur J Obstet Gynecol Reprod Biol; 2008 Jan; 136(1):74-7. PubMed ID: 17007993
[TBL] [Abstract][Full Text] [Related]
5. Estrogen and progesterone receptor expression in postmenopausal tamoxifen-exposed endometrial pathologies.
Cohen I; Beyth Y; Altaras MM; Shapira J; Tepper R; Cardoba M; Yigael D; Figer A; Fishman A; Berenhein J
Gynecol Oncol; 1997 Oct; 67(1):8-15. PubMed ID: 9345349
[TBL] [Abstract][Full Text] [Related]
6. [Sex hormones in the systemic and local circulation in endometrial hyperplasia and neoplasia: correlation with the activity of estrogen-metabolizing enzymes].
Bochkareva NV; Kolomiets LA; Kondakova IV; Stukanov SL; Tropina TV; Muntian AB
Vopr Onkol; 2008; 54(6):729-33. PubMed ID: 19241848
[TBL] [Abstract][Full Text] [Related]
7. [The relationship between simple and atypical endometrial hyperplasia and endometrial carcinoma].
Borisov I; Maĭnkhard K; Tsankova M
Akush Ginekol (Sofiia); 1996; 35(4):18-20. PubMed ID: 9254559
[TBL] [Abstract][Full Text] [Related]
8. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients.
Cheng WF; Lin HH; Torng PL; Huang SC
Gynecol Oncol; 1997 Aug; 66(2):233-7. PubMed ID: 9264568
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma.
Sutter C; Dallenbach-Hellweg G; Schmidt D; Baehring J; Bielau S; von Knebel Doeberitz M; Gebert J
Int J Gynecol Pathol; 2004 Jan; 23(1):18-25. PubMed ID: 14668545
[TBL] [Abstract][Full Text] [Related]
10. Indication of hysteroscopy in tamoxifen treated breast cancer patients.
Taponeco F; Curcio C; Fasciani A; Giuntini A; Artini PG; Fornaciari G; Petraglia F; Genazzani AR
J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527
[TBL] [Abstract][Full Text] [Related]
11. Correlation between serum estradiol/progesterone ratio and survival length in invasive squamous cell cervical cancer.
Hellberg D; Lindström AK; Stendahl U
Anticancer Res; 2005; 25(1B):611-6. PubMed ID: 15816635
[TBL] [Abstract][Full Text] [Related]
12. [Relationship between serum CA125 level and prognosis in the patients with uterine endometrial carcinoma].
Xie Z; Zhang J; Tan A
Zhonghua Yi Xue Za Zhi; 2001 Dec; 81(23):1456-7. PubMed ID: 11930622
[TBL] [Abstract][Full Text] [Related]
13. Vaginal ring delivering estradiol and progesterone: a possible alternative to relieve climacteric symptoms.
Ben-Chetrit A; Hochner-Celnikier D; Lindenberg T; Zacut D; Shimonovitz S; Gelber H; Spitz IM
Isr Med Assoc J; 2005 May; 7(5):302-6. PubMed ID: 15909462
[TBL] [Abstract][Full Text] [Related]
14. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
[TBL] [Abstract][Full Text] [Related]
15. Ovarian stromal hyperplasia and ovarian vein steroid levels in relation to endometrioid endometrial cancer.
Jongen VH; Hollema H; van der Zee AG; Santema JG; Heineman MJ
BJOG; 2003 Jul; 110(7):690-5. PubMed ID: 12842061
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of LH/hCG receptors in endometrial hyperplasia and carcinoma in anovulatory women.
Konishi I; Koshiyama M; Mandai M; Kuroda H; Yamamoto S; Nanbu K; Komatsu T; Matsushita K; Rao CV; Mori T
Gynecol Oncol; 1997 May; 65(2):273-80. PubMed ID: 9159337
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of endometrial cancer and hyperplasia in non-symptomatic overweight and obese women.
Viola AS; Gouveia D; Andrade L; Aldrighi JM; Viola CF; Bahamondes L
Aust N Z J Obstet Gynaecol; 2008 Apr; 48(2):207-13. PubMed ID: 18366497
[TBL] [Abstract][Full Text] [Related]
18. Frequency and characteristics of endometrial carcinoma and atypical hyperplasia detected on routine infertility investigations in young women: a report of six cases.
Fujiwara H; Ogawa S; Motoyama M; Takei Y; Machida S; Taneichi A; Ohwada M; Suzuki M
Hum Reprod; 2009 May; 24(5):1045-50. PubMed ID: 19189994
[TBL] [Abstract][Full Text] [Related]
19. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
[TBL] [Abstract][Full Text] [Related]
20. [Structural chromosome aberrations in the peripheral blood lymphocytes in patients with precancer and endometrial cancer].
Polishchuk LZ; Nesina IP
Tsitol Genet; 1995; 29(3):17-24. PubMed ID: 7676506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
